Why Methylene Blue Have to Be Always Present in the Stocking of Emergency Antidotes

  • Baldo C
  • Silva L
  • Arcencio L
  • et al.
3Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.
Get full text

Abstract

© 2018 Bentham Science Publishers. Evidence-based review of the existing literature ultimately recommends stocking of Methylene Blue (MB) as an emergency antidote in the United States. The same is reported around the world in Japan, Greece, Italy and Canada. The observation that MB is always present as the main antidote required in emergency and critical care units calls for a revisit on its effects on the NO/cGMP system to reemphasize its multisystem actions. Therefore, the present review aimed to display the role of MB in emergency units, concerning: 1) Polytrauma and circulatory shock; 2) Neuroprotection, 3) Anaphylaxis and, 4) Overdose and poisoning.

Cite

CITATION STYLE

APA

Baldo, C. F., Silva, L. M., Arcencio, L., Albuquerque, A. A. S., Celotto, A. C., Basile-Filho, A., & Evora, P. R. B. (2018). Why Methylene Blue Have to Be Always Present in the Stocking of Emergency Antidotes. Current Drug Targets, 19(13), 1550–1559. https://doi.org/10.2174/1389450119666180403100410

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free